Non-substantive Change Request Justification

Emerging Infections Programs (EIP)

OMB Control Number 0920-0978

Expiration Date: 04/30/2022

Program Contact

Sonja Mali Nti-Berko

Emerging Infections Programs (EIP)

Division of Preparedness and Emerging Infections

National Center for Emerging and Zoonotic Infectious Diseases

Centers for Disease Control and Prevention

1600 Clifton Rd, MS-C18

Atlanta, GA 30329

Phone: (404) 488-4780

E-mail: skm5@cdc.gov

Submission Date: August 20, 2021

Table of Contents and Attachments

1. Non-Substantive Change Request Justification Document

2. Description of Changes (Attachment #1)

3. Cross-Walk 2021 to 2022 (Attachment #2)

4. ABCs: 2022 ABCs Case Report Form (Attachment #3)

5. FoodNet: FoodNet Active Surveillance Data Elements List (Attachment #4)

6. FoodNet: FoodNet Hemolytic Uremic Syndrome (Attachment #5)

7. FoodNet: Diagnostic Laboratory Practices and Volume Data Elements List (Attachment #6)

8. FluSurv-NET: Influenza Hospitalization Surveillance Network Case Report Form (Attachment #7)

9. FluSurv-NET: FluSurv-NET/RSV-NET Hospital Laboratory Survey (Attachment #8)

10. HAIC: Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form (Attachment #9)

11. HAIC: Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form (Attachment #10)

12. HAIC: CDI Case Report and Treatment Form (Attachment #11)

13. HAIC: CDI Annual Surveillance Officers Survey (Attachment #12)

14. HAIC: Annual Survey of Laboratory Testing Practices for C. difficile Infections (Attachment #13)

15. HAIC: Candidemia Case Report (Attachment #14)

16. HAIC: Laboratory Testing Practices for Candidemia Questionnaire (Attachment #15)

17. HAIC: Invasive Staphylococcus aureus Laboratory Survey: Use of Nucleic Acid Amplification Testing (NAAT) (Attachment #16)

Justification for Change Request for OMB 0920-0978

This is a nonmaterial/non-substantive change request for OMB No. 0920-0978, expiration date 04/30/2022, for the Emerging Infections Programs (EIP). All requested changes represent minor modifications to already-approved instruments including revised formatting, rewording, new answer options, and the addition/subtraction of a limited number of questions. Larger changes are being packaged together into a revision ICR that will be submitted later.

The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions, local health departments, public health and clinical laboratories, infection control professionals, and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases.

Activities of the EIPs fall into the following general categories: (1) active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease.

Activities in the EIP Network in which all applicants must participate are:

• Active Bacterial Core surveillance (ABCs): active population-based laboratory surveillance for invasive bacterial diseases.

• Foodborne Diseases Active Surveillance Network (FoodNet): active population-based laboratory surveillance to monitor the incidence of select enteric diseases.

• Influenza Hospitalization Surveillance Network (FluSurv-NET): active population-based surveillance for laboratory confirmed influenza-related hospitalizations.

• Healthcare-Associated Infections-Community Interface (HAIC) surveillance: active population-based surveillance for healthcare-associated pathogens and infections.

This non-substantive change request is for changes to the disease-specific data elements for ABCs, FoodNet, FluSurv-NET, and HAIC. The changes made to all forms under this non-substantive request will aid in improving surveillance efficiency and data quality to clarify the burden of disease and possible risk factors for disease. This information can be used to inform strategies for preventing disease and negative outcomes. Specifically, changes were made for clarification purposes, to assist data collectors in capturing data in a standardized fashion to improve accuracy. As a result of proposed changes, the estimated annualized burden is expected to increase by 406 hours, from 38,894 to 39,300. The data elements and justifications are described below.

The forms for which approval for changes are being sought include:

ABCs:

1. 2022 ABCs Case Report Form (Attachment 3)

Food Net:

2. FoodNet Active Surveillance Data Elements List (Attachment 4)

3. FoodNet Hemolytic Uremic Syndrome (Attachment 5)

4. Diagnostic Laboratory Practices and Volume Data Elements List (Attachment 6)

FluSurv-NET:

5. FluSurv-Net Influenza Hospitalization Surveillance Network Case Report Form (Attachment 7)

6. FluSurv-NET/RSV-NET Laboratory Survey (Attachment 8)

HAIC:

7. 2020 Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form (Attachment 9)

8. 2020 Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form (Attachment 10)

9. CDI Case Report and Treatment Form (Attachment 11)

10. CDI Annual Surveillance Officers Survey (Attachment 12)

11. Annual Survey of Laboratory Testing Practices for C. difficile Infections (Attachment 13)

12. Candidemia Case Report (Attachment 14)

13. Laboratory Testing Practices for Candidemia Questionnaire (Attachment 15)

14. Invasive Staphylococcus aureus Laboratory Survey: Use of Nucleic Acid Amplification Testing (NAAT) (Attachment 16)

Estimated Annualized Burden Hours

As a result of proposed changes to forms highlighted in yellow, the estimated annualized burden is expected to increase by 406 hours, from 38,894 to 39,300. The figures highlighted in red are the forms where there was a change in burden hours.

The following table is updated for the entire 0920-0978 burden table. The forms included in this change request are highlighted:

Type of Respondent	Form Name	No. of respondents	No. of responses per respondent	Avg. burden per response (in hours)	Current	After Proposed Changes
State Health Department	ABCs Case Report Form	10	808	20/60	2697	2697
	ABCs Invasive Pneumococcal Disease in Children Case Report Form	10	22	10/60	37	37
	ABCs H. influenzae Neonatal Sepsis Expanded Surveillance Form	10	6	10/60	10	10
	ABCs Severe GAS Infection Supplemental Form	10	136	20/60	453	453
	ABCs Neonatal Infection Expanded Tracking Form	10	37	20/60	123	123
	FoodNet Campylobacter	10	970	21/60	3395	3395
	FoodNet Cyclospora	10	42	10/60	70	70
	FoodNet Listeria monocytogenes	10	16	20/60	53	53
	FoodNet Salmonella	10	855	21/60	2993	2993
	FoodNet Shiga toxin producing E. coli	10	290	20/60	967	967
	FoodNet Shigella	10	234	10/60	390	390
	FoodNet Vibrio	10	46	10/60	77	77
	FoodNet Yersinia	10	55	10/60	92	92
	FoodNet Hemolytic Uremic Syndrome	10	10	1	100	100
	FoodNet Clinical Laboratory Practices and Testing Volume	10	70	20/60	233	233
	FluSurv-Net Influenza Hospitalization Surveillance Network Case Report Form	10	764	25/60	2768	3183

	FluSurv-Net Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (English)	10	333	5/60	278	278
	FluSurv-Net Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (Spanish)	10	333	5/60	278	278
	FluSurv-Net Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)	10	333	5/60	278	278
	FluSurv-NET Laboratory Survey	10	16	10/60	38	26
	HAIC - MuGSI Case Report Form for Carbapenem-resistant Enterobacteriaceae (CRE) and Acinetobacter baumannii (CRAB)	10	500	28/60	2333	2333
	HAIC - MuGSI Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL)	10	1104	28/60	5152	5152
	HAIC - Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form	10	340	28/60	1587	1587
	HAIC - Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form	10	584	28/60	2725	2725
	HAIC - CDI Case Report and Treatment Form	10	1650	38/60	10450	10450
	HAIC Candidemia Case Report	10	200	30/60	1134	1134
	HAIC- Annual Survey of Laboratory Testing Practices for C. difficile Infections.	10	16	15/60	51	51
	HAIC- CDI Annual Surveillance Officers Survey	10	1	15/60	3	3
	HAIC- Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey (LTCF)	10	45	5/60	38	38

	HAIC- Invasive Staphylococcus aureus Laboratory Survey: Use of Nucleic Acid Amplification Testing (NAAT)	10	11	20/60	37	37
	HAIC- Invasive Staphylococcus aureus Supplemental Surveillance Officers Survey	10	1	10/60	17	17
	HAIC- Laboratory Testing Practices for Candidemia Questionnaire	10	20	12/60	37	40
TOTAL					38,894	39,300